PhalconBio GmbH

Private

WädenswilHealthcare & Life Scienceshttps://phalconbio.com/

Last Round

Grant

Feb 18, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PhalconBio GmbH is a biotechnology company that develops antimicrobial precision medicines using engineered bacteriophages to combat antibiotic resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

engineered bacteriophagephage therapyantimicrobial resistanceprecision medicineengineered phage therapeuticsEPTmultidrug-resistant bacteriasynthetic biologydrug discoveryantibiotic alternativespulmonary infectionbiotech startupsuperbug treatmentpreclinical researchphage tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhalconBio GmbH Comps

Public and private peers based on sector, stage, and business model.

PhalconBio GmbH comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PhalconBio GmbH Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 18, 2025

View all Funding Rounds

PhalconBio GmbH Investors

Notable investors and investment history

PhalconBio GmbH investors
Investor	Rounds
PACE (Pathways to Antimicrobial Clinical Efficacy)	Grant
Innovate UK	Grant
Medicines Discovery Catapult	Grant
LifeArc	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 12, 2026
Monthly visitors increased 1251% MoM, reaching 1.3K.

View all signals

PhalconBio GmbH Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PhalconBio GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PhalconBio GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersWädenswil

Employee Range4

Year FoundedN/A

Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.